Consultant in Clinical Oncology at The Christie, Honorary Senior Clinical Lecturer at The University of Manchester
The Christie main site: 0 161 446 8583, The Christie at Oldham: 0161 446 7705/6
The Christie main site: 0161 446 3478, The Christie at Oldham: 0161 918 7750
BSc (Med Phys), MD (Med), PhD (Med), MA (Clin Ed),MRCR
Non-melanoma skin cancers, palliative radiotherapy (not site-specific)
Started at The Christie (Year)
- Treating patients with skin cancer by the means of radiotherapy (superficial, electron, photon and brachytherapy)
- Treating patients with palliative radiotherapy (not side specific)
- Clinical lead for skin cancer (non-surgical treatment) and for palliative radiotherapy
- Member of Drug and Therapeutic Committee
Dr Agata Rembielak is a highly experienced Clinical Oncology Consultant with an excellent knowledge of advanced radiation technology and brachytherapy.
She graduated from medicine and medical physics in Poland. She then enrolled in specialist training in radiation oncology and clinical-research fellowships which she undertook in Poland, Australia and Canada. She holds a PhD in medical sciences. In 2007 she joined The Christie Hospital as a clinical research fellow, leading to a MD qualification from the University of Manchester. She now holds a substantive consultant post at The Christie. In 2017 she was appointed Honorary Senior Lecturer at The University of Manchester. At The Christie at Oldham she set up and successfully runs the Rapid Access Palliative Radiotherapy Clinic.
At a national level Dr Rembielak has been a faculty for The Royal College of Radiologists (RCR) Skin Cancer Day and has organised and lectured at RCR Palliative Radiotherapy Day. She regularly contributes to RCR e-learning in the form of webinars and on line tutorials. She represents RCR at the British Association of Dermatologist and the National Institute for Health and Care Excellence (NICE). She collaborates very closely with Macmillan Cancer Support in the area of skin cancer and palliative and supportive management in cancer patients. At an international level Dr Rembielak is a very active and respected member of the European Society for Radiotherapy and Oncology (ESTRO). She is a course director at the ESTRO live course entitled “Multidisciplinary management of non-melanoma skin cancer”. Dr Rembielak has been appointed to the Scientific Committee for the World Congress of Brachytherapy in Vienna 2020 and NCRI Conference 2020 in Belfast. She is an editor at the Clinical Oncology journal and at Journal of Contemporary Brachytherapy. She acts as a reviewer for many national and international scientific journals.
She has been recognized internationally and has been an invited speaker at many national and international conferences and workshops.
Dr Rembielak’s research interest includes non-melanoma skin cancer, particularly the role of radiotherapy and brachytherapy in skin cancer management, palliative radiotherapy and geriatric oncology. At a national level Dr Rembielak is a member of Skin Cancer Group at The National Cancer Research Institute (NCRI) and leads radiation oncology studies within the group. Currently she is CI for an NCRI clinical trial looking at postoperative radiotherapy in high risk cutaneous SCC. At an international level she is a member of GEC-ESTRO H&N and Skin Working Group and co-authored ESTRO skin brachytherapy guidelines.
Her other research interests include technical radiotherapy and systemic treatments in concurrent and sequential settings with radiotherapy.
Her research and clinical activity have led to an impressive record of papers in peer-reviewed scientific journals, book chapters and presentations.
Dr Rembielak is recognised as a knowledgeable and respected medical educator and has been involved in teaching across many staff groups. She holds an MA degree in Clinical Education from Edge Hill University, UK. She acts as an examiner at The Christie FRCR Part 2 exam course. Her expertise and enthusiasm manifest in considerable contribution to education and training in radiation and clinical oncology at a regional, national and international level. She also regularly contributes to teaching in dermatology, radiography, surgical and plastic oncology.